Frontiers in Cardiovascular Medicine (Nov 2024)

Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets

  • Han Zhang,
  • Han Zhang,
  • Jiulu Zhao,
  • Jiulu Zhao,
  • Jizhang Yu,
  • Jizhang Yu,
  • Xi Zhang,
  • Xi Zhang,
  • Shuan Ran,
  • Shuan Ran,
  • Song Wang,
  • Song Wang,
  • Weicong Ye,
  • Weicong Ye,
  • Zilong Luo,
  • Zilong Luo,
  • Xiaohan Li,
  • Xiaohan Li,
  • Yanglin Hao,
  • Yanglin Hao,
  • Junjie Zong,
  • Junjie Zong,
  • Ran Li,
  • Ran Li,
  • Longyong Lai,
  • Longyong Lai,
  • Kexiao Zheng,
  • Kexiao Zheng,
  • Pinyan Huang,
  • Pinyan Huang,
  • Cheng Zhou,
  • Cheng Zhou,
  • Jie Wu,
  • Jie Wu,
  • Jie Wu,
  • Yuan Li,
  • Yuan Li,
  • Yuan Li,
  • Jiahong Xia,
  • Jiahong Xia,
  • Jiahong Xia

DOI
https://doi.org/10.3389/fcvm.2024.1489438
Journal volume & issue
Vol. 11

Abstract

Read online

Cardiovascular disease (CVD) is responsible for approximately 30% of annual global mortality rates, yet existing treatments for this condition are considered less than ideal. Despite being previously overlooked, lactate, a byproduct of glycolysis, is now acknowledged for its crucial role in the cellular functions of the cardiovascular system. Recent studies have shown that lactate influences the proliferation, differentiation, and activation of immune cells through its modulation of post-translational protein modifications, thereby affecting the development and prognosis of cardiovascular disease. Consequently, there has been a notable increase in interest towards drug targets targeting lactylation in immune cells, prompting further exploration. In light of the swift advancements in this domain, this review article is dedicated to examining lactylation in cardiovascular disease and potential drug targets for regulating lactylation, with the aim of enhancing comprehension of this intricate field.

Keywords